NASDAQ Gainers: BG Medicine (NASDAQ:BGMD), MagneGas Corporation (NASDAQ:MNGA), Synta Pharmaceuticals (NASDAQ:SNTA), Sinovac Biotech (NASDAQ:SVA)

BG Medicine (NASDAQ:BGMD) reached a new 52-week high during mid-day trading on Thursday following a better than expected earnings announcement, AnalystRatingsNetwork reports. BG Medicine, Inc. (NASDAQ:BGMD) shares after opening at $2.06 moved to $2.36 on last trade day and at the end of the day closed at $1.92. Company price to sales ratio in past twelve months was calculated as 13.40 and price to cash ratio as 4.74. BG Medicine, Inc. (NASDAQ:BGMD) showed a positive weekly performance of 47.69%.

MagneGas Corporation (Nasdaq:MNGA) announced that it is providing four demolition projects with MagneGas fuel for their torch cutting. These projects are sourced through existing MagneGas distributors Blue Water Industrial of Michigan and AWISCO Corp of New York. MagneGas Corporation (NASDAQ:MNGA) shares advanced 20.00% in last trading session and ended the day on $1.50. MNGA return on equity ratio is recorded as -87.60% and its return on assets is -81.20%. MagneGas Corporation (NASDAQ:MNGA) yearly performance is 26.05%.

Shares of Synta Pharmaceuticals (NASDAQ:SNTA) , a clinical-stage small-molecule drug developer aimed at treating cancer and chronic inflammatory diseases, soared as much as 21% after announcing positive interim results from its ENCHANT-1 study of experimental metastatic breast cancer therapy ganetespib at the European Breast Cancer Conference. Synta Pharmaceuticals Corp. (NASDAQ:SNTA) shares moved up 9.47% in last trading session and was closed at $5.20 while trading in range of $5.02 – $5.51 – Synta Pharmaceuticals Corp. (NASDAQ:SNTA) year to date (YTD) performance is -0.76%.

Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China,announced its unaudited fourth quarter and full year financial results for the period ended December 31, 2013. Sinovac Biotech Ltd. (NASDAQ:SVA) weekly performance is 24.54%. On last trading day company shares ended up $8.07. Sinovac Biotech Ltd. (NASDAQ:SVA) distance from 50-day simple moving average (SMA50) is 23.63%. Analysts mean target price for the company is $6.75.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *